Key facts
- CARB-X is a other based in Boston, Massachusetts with 19 tracked portfolio companies.
- Notable positions include Visby Medical, Peptilogics, Pattern (Discovery Tools), Lumen Bioscience, Clarametyx Biosciences.
About CARB-X
Founded in 2016, CARB-X is a not-for-profit investment firm led by Boston University based in Boston, Massachusetts. The firm supports companies through the early stages of product development and phase 1. The firm provides grant funding for antibiotics, vaccines, rapid diagnostics, and other life-saving products that target the most serious forms of Gram-negative bacteria and difficult-to-treat bacteria including C. difficile.
Free account
See the whole book
- ·The book's top 25 — of 19 recorded positions
- ·Watchlist + alerts for CARB-X's activity
Create free account
No card required
Portfolio, priced
19 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Visby Medical | — | $866.0M | — | |
| Peptilogics | — | $150.0M | — | |
| Pattern (Discovery Tools) | — | $105.0M | — | |
| Lumen Bioscience | — | $92.8M | — | |
| Clarametyx Biosciences | — | $92.0M | — | |
| Snipr Biome | — | $50.0M | — | |
| Baebies | — | $38.0M | — | |
| Centauri Therapeutics | — | $15.8M | — | |
| Pearl Diagnostics | — | $15.0M | — | |
| Oxford Drug Design | — | $12.7M | — | |
| Zeteo Tech | — | $11.5M | — | |
| Immunethep | — | $3.6M | — | |
| Novel Microdevices | — | — | — | |
| LimmaTech Biologics | — | — | — | |
| Lytica Therapeutics | — | — | — | |
| + 4 more companies · a free account shows the top of the book | ||||
Frequently asked
- What companies does CARB-X invest in?
- CARB-X has 19 recorded portfolio companies, including Visby Medical, Peptilogics, Pattern (Discovery Tools), Lumen Bioscience.